Expression	O
of	O
c-jun	B-DNA
,	I-DNA
jun	I-DNA
B	I-DNA
and	I-DNA
jun	I-DNA
D	I-DNA
proto-oncogenes	I-DNA
in	O
human	B-cell_type
peripheral-blood	I-cell_type
granulocytes	I-cell_type
.	O

We	O
have	O
found	O
that	O
purified	B-cell_type
human	I-cell_type
peripheral-blood	I-cell_type
granulocytes	I-cell_type
express	O
constitutively	O
significant	O
levels	O
of	O
proto-oncogenes	B-DNA
c-jun	B-RNA
,	I-RNA
jun	I-RNA
B	I-RNA
and	I-RNA
jun	I-RNA
D	I-RNA
mRNA	I-RNA
.	O

Upon	O
functional	O
activation	O
of	O
granulocytes	B-cell_type
by	O
4	O
beta-phorbol	O
12-myristate	O
13-acetate	O
(	O
PMA	O
)	O
,	O
the	O
levels	O
of	O
c-jun	B-RNA
,	I-RNA
jun	I-RNA
B	I-RNA
and	I-RNA
jun	I-RNA
D	I-RNA
transcripts	I-RNA
were	O
increased	O
.	O

The	O
three	O
jun	B-DNA
genes	I-DNA
showed	O
a	O
similar	O
time	O
course	O
in	O
their	O
induction	O
by	O
PMA	O
,	O
maximal	O
mRNA	O
levels	O
being	O
reached	O
after	O
60	O
min	O
of	O
induction	O
.	O

These	O
results	O
suggest	O
that	O
expression	O
of	O
c-jun	B-DNA
,	O
jun	B-DNA
B	I-DNA
and	O
jun	B-DNA
D	I-DNA
genes	I-DNA
might	O
be	O
involved	O
in	O
terminal	B-cell_type
granulocyte	I-cell_type
differentiation	O
or	O
in	O
regulating	O
granulocyte	B-cell_type
functionality	O
.	O

Biochem	NULL
.	NULL

J	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
273	NULL
,	NULL
477-479	NULL
(	NULL
Printed	NULL
in	NULL
Great	NULL
Britain	NULL
)	NULL
477	NULL
Expression	NULL
of	NULL
c-jun	NULL
,	NULL
jun	NULL
B	NULL
and	NULL
jun	NULL
D	NULL
proto-oncogenes	NULL
in	NULL
human	NULL
peripheral-blood	NULL
granulocytes	NULL
Faustino	NULL
MOLLINEDO	NULL
,	NULL
*	NULL
Maria	NULL
Jose	NULL
VAQUERIZOt	NULL
and	NULL
Jose	NULL
Ramon	NULL
NARANJOtt	NULL
*Centro	NULL
de	NULL
Investigaciones	NULL
Biologicas	NULL
,	NULL
C.S.L.C	NULL
.	NULL

,	NULL
Velazquez	NULL
144	NULL
,	NULL
28006-Madrid	NULL
,	NULL
and	NULL
tInstituto	NULL
Cajal	NULL
de	NULL
Neurociencias	NULL
,	NULL
C.S.I.C	NULL
.	NULL

,	NULL
Doctor	NULL
Arce	NULL
37	NULL
,	NULL
28002-Madrid	NULL
,	NULL
Spain	NULL
We	NULL
have	NULL
found	NULL
that	NULL
purified	NULL
human	NULL
peripheral-blood	NULL
granulocytes	NULL
express	NULL
constitutively	NULL
significant	NULL
levels	NULL
of	NULL
proto-oncogenes	NULL
c-jun	NULL
,	NULL
jun	NULL
B	NULL
and	NULL
jun	NULL
D	NULL
mRNA	NULL
.	NULL

Upon	NULL
functional	NULL
activation	NULL
of	NULL
granulocytes	NULL
by	NULL
4	NULL
$	NULL
-phorbol	NULL
12-myristate	NULL
13-acetate	NULL
(	NULL
PMA	NULL
)	NULL
,	NULL
the	NULL
levels	NULL
of	NULL
c-jun	NULL
,	NULL
jun	NULL
B	NULL
and	NULL
jun	NULL
D	NULL
transcripts	NULL
were	NULL
increased	NULL
.	NULL

The	NULL
three	NULL
jun	NULL
genes	NULL
showed	NULL
a	NULL
similar	NULL
time	NULL
course	NULL
in	NULL
their	NULL
induction	NULL
by	NULL
PMA	NULL
,	NULL
maximal	NULL
mRNA	NULL
levels	NULL
being	NULL
reached	NULL
after	NULL
60	NULL
min	NULL
of	NULL
induction	NULL
.	NULL

These	NULL
results	NULL
suggest	NULL
that	NULL
expression	NULL
of	NULL
c-jun	NULL
,	NULL
jun	NULL
B	NULL
and	NULL
jun	NULL
D	NULL
genes	NULL
might	NULL
be	NULL
involved	NULL
in	NULL
terminal	NULL
granulocyte	NULL
differentiation	NULL
or	NULL
in	NULL
regulating	NULL
granulocyte	NULL
functionality	NULL
.	NULL

INTRODUCTION	NULL
The	NULL
proto-oncogene	NULL
c-jun	NULL
encodes	NULL
for	NULL
the	NULL
transcriptional	NULL
factor	NULL
AP-1	NULL
[	NULL
1,2	NULL
]	NULL
.	NULL

This	NULL
c-Jun/AP-1	NULL
protein	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
be	NULL
associated	NULL
with	NULL
the	NULL
c-Fos	NULL
oncoprotein	NULL
in	NULL
some	NULL
transcriptional	NULL
activators	NULL
[	NULL
3-6	NULL
]	NULL
.	NULL

Two	NULL
other	NULL
c-jun-related	NULL
cDNAs	NULL
have	NULL
been	NULL
isolated	NULL
(	NULL
jun	NULL
B	NULL
and	NULL
jun	NULL
D	NULL
)	NULL
,	NULL
whose	NULL
encoded	NULL
proteins	NULL
show	NULL
extensive	NULL
amino	NULL
acid	NULL
sequence	NULL
identity	NULL
with	NULL
c-Jun/AP-1	NULL
and	NULL
are	NULL
able	NULL
to	NULL
form	NULL
nuclear	NULL
complexes	NULL
with	NULL
c-Fos	NULL
or	NULL
Fos-related	NULL
proteins	NULL
[	NULL
7,8	NULL
]	NULL
.	NULL

It	NULL
has	NULL
been	NULL
found	NULL
that	NULL
human	NULL
granulocytes	NULL
express	NULL
constitutively	NULL
high	NULL
levels	NULL
of	NULL
c-fos	NULL
mRNA	NULL
[	NULL
9-12	NULL
]	NULL
,	NULL
which	NULL
were	NULL
increased	NULL
upon	NULL
cell	NULL
activation	NULL
by	NULL
distinct	NULL
stimuli	NULL
[	NULL
9-13	NULL
]	NULL
.	NULL

Thus	NULL
it	NULL
was	NULL
of	NULL
importance	NULL
to	NULL
examine	NULL
the	NULL
expression	NULL
of	NULL
the	NULL
jun	NULL
family	NULL
genes	NULL
in	NULL
granulocytes	NULL
.	NULL

In	NULL
this	NULL
context	NULL
,	NULL
the	NULL
expression	NULL
of	NULL
c-jur	NULL
mRNA	NULL
in	NULL
human	NULL
myelomonocytic	NULL
cells	NULL
has	NULL
been	NULL
recently	NULL
reported	NULL
[	NULL
14	NULL
]	NULL
.	NULL

The	NULL
present	NULL
study	NULL
was	NULL
performed	NULL
to	NULL
analyse	NULL
the	NULL
expression	NULL
of	NULL
the	NULL
three	NULL
proto-oncogenes	NULL
c-jun	NULL
,	NULL
jun	NULL
B	NULL
and	NULL
jun	NULL
D	NULL
at	NULL
the	NULL
mRNA	NULL
level	NULL
in	NULL
freshly	NULL
isolated	NULL
human	NULL
peripheral-blood	NULL
granulocytes	NULL
.	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
Cells	NULL
Granulocytes	NULL
were	NULL
obtained	NULL
from	NULL
fresh	NULL
human	NULL
peripheral	NULL
blood	NULL
after	NULL
dextran-induced	NULL
sedimentation	NULL
of	NULL
erythrocytes	NULL
and	NULL
density-gradient	NULL
centrifugation	NULL
of	NULL
the	NULL
leucocyte-rich	NULL
supernatant	NULL
on	NULL
Lymphoprep	NULL
,	NULL
and	NULL
hypo-osmotic	NULL
lysis	NULL
of	NULL
contaminating	NULL
erythrocytes	NULL
as	NULL
previously	NULL
described	NULL
[	NULL
15	NULL
]	NULL
.	NULL

Isolated	NULL
granulocytes	NULL
contained	NULL
more	NULL
than	NULL
98	NULL
%	NULL
,	NULL
neutrophils	NULL
and	NULL
less	NULL
than	NULL
1	NULL
%	NULL
contaminating	NULL
mononuclear	NULL
cells	NULL
,	NULL
as	NULL
assessed	NULL
by	NULL
Giemsa-Wright	NULL
stain	NULL
and	NULL
flow-cytometric	NULL
analysis	NULL
.	NULL

Cell	NULL
viability	NULL
was	NULL
evaluated	NULL
by	NULL
Trypan	NULL
Blue	NULL
exclusion	NULL
,	NULL
and	NULL
was	NULL
always	NULL
higher	NULL
than	NULL
98	NULL
%	NULL
.	NULL

The	NULL
human	NULL
promyelocytic	NULL
cell	NULL
line	NULL
HL60	NULL
[	NULL
16	NULL
]	NULL
and	NULL
the	NULL
human	NULL
promonocytic	NULL
cell	NULL
line	NULL
U937	NULL
were	NULL
grown	NULL
at	NULL
37	NULL
°C	NULL
in	NULL
a	NULL
humidified	NULL
atmosphere	NULL
(	NULL
CO	NULL
,	NULL
/air	NULL
,	NULL
1:19	NULL
)	NULL
in	NULL
RPMI	NULL
1640	NULL
medium	NULL
supplemented	NULL
with	NULL
10	NULL
%	NULL
(	NULL
v/v	NULL
)	NULL
heat-inactivated	NULL
fetal-calf	NULL
serum	NULL
,	NULL
2	NULL
mM-L-glutamine	NULL
,	NULL
penicillin	NULL
(	NULL
100	NULL
units/ml	NULL
)	NULL
and	NULL
gentamycin	NULL
(	NULL
24	NULL
ug/ml	NULL
)	NULL
.	NULL

RNA	NULL
analysis	NULL
Total	NULL
RNA	NULL
was	NULL
isolated	NULL
by	NULL
the	NULL
guanidine	NULL
isothiocyanate/CsCl	NULL
method	NULL
[	NULL
17	NULL
]	NULL
and	NULL
analysed	NULL
(	NULL
10	NULL
ug	NULL
of	NULL
RNA	NULL
)	NULL
,	NULL
either	NULL
by	NULL
electro-phoresis	NULL
through	NULL
1.1	NULL
%	NULL
(	NULL
w/v	NULL
)	NULL
agarose/formaldehyde	NULL
gels	NULL
,	NULL
fol-	NULL
lowed	NULL
by	NULL
transfer	NULL
to	NULL
Hybond-N	NULL
nylon	NULL
membranes	NULL
,	NULL
or	NULL
by	NULL
dot-blot	NULL
hybridization	NULL
as	NULL
previously	NULL
described	NULL
[	NULL
18	NULL
]	NULL
.	NULL

*°P-labelled	NULL
cDNA	NULL
probes	NULL
were	NULL
prepared	NULL
using	NULL
the	NULL
random	NULL
oligonucleotide	NULL
priming	NULL
method	NULL
(	NULL
Oligo-Labelling	NULL
Kit	NULL
;	NULL
Pharm-acia	NULL
)	NULL
to	NULL
a	NULL
specific	NULL
radioactivity	NULL
equal	NULL
to	NULL
,	NULL
or	NULL
higher	NULL
than	NULL
,	NULL
7x	NULL
10°	NULL
c.p.m./ug	NULL
of	NULL
cDNA	NULL
.	NULL

The	NULL
plasmid	NULL
AH119	NULL
[	NULL
19	NULL
]	NULL
,	NULL
containing	NULL
c-jun	NULL
,	NULL
was	NULL
generously	NULL
provided	NULL
by	NULL
Dr.	NULL
R.	NULL
Bravo	NULL
(	NULL
Squibb	NULL
Institute	NULL
,	NULL
Princeton	NULL
,	NULL
NJ	NULL
,	NULL
U.S.A.	NULL
)	NULL
.	NULL

cDNA	NULL
probes	NULL
for	NULL
jun	NULL
B	NULL
[	NULL
20	NULL
]	NULL
and	NULL
jur	NULL
D	NULL
[	NULL
21	NULL
]	NULL
were	NULL
kindly	NULL
provided	NULL
by	NULL
Dr.	NULL
P.	NULL
Sassone-Corsi	NULL
(	NULL
LGME	NULL
,	NULL
CNRS	NULL
,	NULL
Strasbourg	NULL
,	NULL
France	NULL
)	NULL
.	NULL

The	NULL
plasmid	NULL
pAc	NULL
18.1	NULL
[	NULL
22	NULL
]	NULL
was	NULL
used	NULL
as	NULL
a	NULL
probe	NULL
for	NULL
$	NULL
-actin	NULL
.	NULL

#	NULL
-Actin	NULL
mRNA	NULL
was	NULL
employed	NULL
as	NULL
a	NULL
control	NULL
probe	NULL
.	NULL

Northern	NULL
and	NULL
dot-blots	NULL
were	NULL
prehybridized	NULL
at	NULL
42	NULL
°C	NULL
for	NULL
24	NULL
h	NULL
in	NULL
a	NULL
buffer	NULL
containing	NULL
50	NULL
%	NULL
formamide	NULL
,	NULL
0.75	NULL
m-NaCl	NULL
,	NULL
0.2	NULL
%	NULL
SDS	NULL
,	NULL
25	NULL
mM-EDTA	NULL
,	NULL
5	NULL
x	NULL
Denhardt	NULL
's	NULL
solution	NULL
(	NULL
1	NULL
x	NULL
Denhardt	NULL
's	NULL
is	NULL
0.02	NULL
%	NULL
BSA/0.02	NULL
%	NULL
Ficoll/0.02	NULL
%	NULL
polyvinylpyrrolidone	NULL
)	NULL
,	NULL
25	NULL
mm-Pipes	NULL
(	NULL
pH	NULL
6.8	NULL
)	NULL
and	NULL
salmon	NULL
sperm	NULL
DNA	NULL
(	NULL
100	NULL
ug/ml	NULL
)	NULL
.	NULL

Blots	NULL
then	NULL
were	NULL
hybridized	NULL
in	NULL
the	NULL
above	NULL
buffer	NULL
containing	NULL
1	NULL
x	NULL
Denhardt	NULL
's	NULL
solution	NULL
,	NULL
10	NULL
%	NULL
(	NULL
w/v	NULL
)	NULL
dextran	NULL
sulphate	NULL
and	NULL
10	NULL
``	NULL
c.p.m	NULL
.	NULL

of	NULL
probe	NULL
at	NULL
42	NULL
°C	NULL
for	NULL
16-24	NULL
h.	NULL
After	NULL
hybridization	NULL
,	NULL
the	NULL
blots	NULL
were	NULL
washed	NULL
twice	NULL
in	NULL
2xSSC	NULL
(	NULL
1xSSC	NULL
is	NULL
0.15	NULL
m-NaC1/0.015	NULL
m-sodium	NULL
citrate	NULL
)	NULL
/0.1	NULL
%	NULL
SDS	NULL
for	NULL
30	NULL
min	NULL
each	NULL
wash	NULL
at	NULL
room	NULL
temperature	NULL
,	NULL
once	NULL
with	NULL
the	NULL
same	NULL
buffer	NULL
at	NULL
42	NULL
°C	NULL
,	NULL
twice	NULL
in	NULL
0.1	NULL
%	NULL
SSC/0.1	NULL
%	NULL
SDS	NULL
for	NULL
15	NULL
min	NULL
at	NULL
42	NULL
°C	NULL
,	NULL
and	NULL
once	NULL
more	NULL
with	NULL
the	NULL
same	NULL
buffer	NULL
for	NULL
15	NULL
min	NULL
at	NULL
60	NULL
°C	NULL
.	NULL

Subsequently	NULL
,	NULL
blots	NULL
were	NULL
air-dried	NULL
and	NULL
exposed	NULL
to	NULL
Kodak	NULL
X-Omat	NULL
film	NULL
with	NULL
enhancing	NULL
screens	NULL
at	NULL
-80	NULL
°C	NULL
.	NULL

Quantitative	NULL
analysis	NULL
of	NULL
the	NULL
autoradiograms	NULL
was	NULL
performed	NULL
by	NULL
integration	NULL
of	NULL
peak	NULL
areas	NULL
after	NULL
scanning	NULL
with	NULL
a	NULL
Molecular	NULL
Dynamics	NULL
300A	NULL
computing	NULL
densitometer	NULL
Fast	NULL
Scan	NULL
.	NULL

Labelled	NULL
probes	NULL
were	NULL
removed	NULL
from	NULL
filters	NULL
by	NULL
immersion	NULL
in	NULL
boiling	NULL
2	NULL
%	NULL
(	NULL
v/v	NULL
)	NULL
glycerol	NULL
for	NULL
2	NULL
min	NULL
.	NULL

Before	NULL
hybridization	NULL
to	NULL
a	NULL
second	NULL
probe	NULL
,	NULL
removal	NULL
of	NULL
radioactivity	NULL
was	NULL
verified	NULL
by	NULL
auto-radiography	NULL
.	NULL

RESULTS	NULL
AND	NULL
DISCUSSION	NULL
Total	NULL
RNA	NULL
was	NULL
extracted	NULL
from	NULL
highly	NULL
purified	NULL
granulocytes	NULL
isolated	NULL
from	NULL
human	NULL
peripheral	NULL
blood	NULL
and	NULL
analysed	NULL
by	NULL
Northern	NULL
and	NULL
dot-blot	NULL
techniques	NULL
using	NULL
specific	NULL
probes	NULL
for	NULL
c-jun	NULL
,	NULL
jun	NULL
B	NULL
and	NULL
jun	NULL
D.	NULL
We	NULL
found	NULL
that	NULL
the	NULL
average	NULL
content	NULL
of	NULL
cell	NULL
RNA	NULL
in	NULL
granulocytes	NULL
ranged	NULL
from	NULL
4.8	NULL
to	NULL
5.6	NULL
ug	NULL
of	NULL
cells	NULL
.	NULL

This	NULL
value	NULL
is	NULL
very	NULL
low	NULL
when	NULL
compared	NULL
with	NULL
that	NULL
found	NULL
in	NULL
other	NULL
cell	NULL
Abbreviations	NULL
used	NULL
:	NULL
PMA	NULL
,	NULL
4	NULL
$	NULL
-phorbol	NULL
12-myristate	NULL
13-acetate	NULL
.	NULL

{	NULL
To	NULL
whom	NULL
correspondence	NULL
should	NULL
be	NULL
sent	NULL
.	NULL

Vol	NULL
.	NULL

273	NULL
478	NULL
Exposure	NULL
time	NULL
C	NULL
PMA	NULL
(	NULL
h	NULL
)	NULL
28	NULL
$	NULL
_-	NULL
»	NULL
c-jun	NULL
~	NULL
24	NULL
18S	NULL
_-	NULL
»	NULL
28	NULL
S	NULL
_-	NULL
»	NULL
c-jun	NULL
_	NULL
ﬂ	NULL
3	NULL
18	NULL
$	NULL
-	NULL
»	NULL
28S	NULL
$	NULL
-	NULL
»	NULL
jun	NULL
B	NULL
w	NULL
j	NULL
3	NULL
18S	NULL
_-	NULL
»	NULL
iz	NULL
‘	NULL
ﬂ	NULL
'	NULL
28S	NULL
$	NULL
-	NULL
»	NULL
jun	NULL
D	NULL
s	NULL
«	NULL
..	NULL
-	NULL
@	NULL
@	NULL
a	NULL
-Actin	NULL
Fig	NULL
.	NULL

1	NULL
.	NULL

Northern-blot	NULL
analysis	NULL
of	NULL
the	NULL
c-jun	NULL
,	NULL
jun	NULL
B	NULL
and	NULL
jur	NULL
D	NULL
mRNA	NULL
in	NULL
human	NULL
peripheral-blood	NULL
granulocytes	NULL
Total	NULL
RNA	NULL
was	NULL
isolated	NULL
from	NULL
unstimulated	NULL
control	NULL
granulocytes	NULL
(	NULL
°C	NULL
``	NULL
)	NULL
as	NULL
well	NULL
as	NULL
from	NULL
granulocytes	NULL
stimulated	NULL
with	NULL
PMA	NULL
(	NULL
20	NULL
ng/ml	NULL
)	NULL
for	NULL
60	NULL
min	NULL
at	NULL
37°C	NULL
(	NULL
PMA	NULL
)	NULL
,	NULL
and	NULL
Northern-blot	NULL
analysis	NULL
was	NULL
carried	NULL
out	NULL
as	NULL
described	NULL
in	NULL
the	NULL
Materials	NULL
and	NULL
methods	NULL
section	NULL
.	NULL

The	NULL
sizes	NULL
of	NULL
the	NULL
transcripts	NULL
for	NULL
c-jun	NULL
(	NULL
~	NULL
2.7	NULL
kb	NULL
and	NULL
~3.4	NULL
kb	NULL
)	NULL
,	NULL
jun	NULL
B	NULL
(	NULL
~	NULL
2.1	NULL
kb	NULL
)	NULL
and	NULL
jun	NULL
D	NULL
(	NULL
~	NULL
2.0	NULL
kb	NULL
)	NULL
are	NULL
indicated	NULL
.	NULL

#	NULL
-Actin	NULL
mRNA	NULL
was	NULL
used	NULL
as	NULL
a	NULL
control	NULL
.	NULL

Autoradiograms	NULL
were	NULL
developed	NULL
after	NULL
3	NULL
or	NULL
24	NULL
h	NULL
of	NULL
exposure	NULL
as	NULL
indicated	NULL
.	NULL

types	NULL
,	NULL
such	NULL
as	NULL
the	NULL
human	NULL
promonocytic	NULL
cell	NULL
line	NULL
U937	NULL
(	NULL
about	NULL
60	NULL
4g	NULL
of	NULL
RNA/10	NULL
``	NULL
cells	NULL
)	NULL
or	NULL
the	NULL
human	NULL
promyelocytic	NULL
cell	NULL
line	NULL
HL60	NULL
(	NULL
about	NULL
40	NULL
4g	NULL
of	NULL
RNA/10*	NULL
cells	NULL
)	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

1	NULL
,	NULL
high	NULL
levels	NULL
of	NULL
c-jun	NULL
,	NULL
jun	NULL
B	NULL
and	NULL
jun	NULL
D	NULL
mRNA	NULL
could	NULL
be	NULL
detected	NULL
constitutively	NULL
in	NULL
unstimulated	NULL
granulocytes	NULL
.	NULL

However	NULL
,	NULL
unstimulated	NULL
granulocytes	NULL
expressed	NULL
much	NULL
higher	NULL
levels	NULL
of	NULL
jun	NULL
B	NULL
and	NULL
jun	NULL
D	NULL
transcripts	NULL
than	NULL
of	NULL
c-jun	NULL
transcripts	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
.	NULL

Unlike	NULL
granulocytes	NULL
,	NULL
uninduced	NULL
U937	NULL
and	NULL
HL6Q	NULL
cells	NULL
did	NULL
not	NULL
express	NULL
detectable	NULL
levels	NULL
of	NULL
c-jun	NULL
,	NULL
jun	NULL
B	NULL
and	NULL
jun	NULL
D	NULL
mRNA	NULL
(	NULL
results	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Treatment	NULL
of	NULL
granulocytes	NULL
with	NULL
the	NULL
cell-activating	NULL
agent	NULL
12-myristate	NULL
13-acetate	NULL
(	NULL
PMA	NULL
)	NULL
enhanced	NULL
the	NULL
levels	NULL
of	NULL
c-jun	NULL
,	NULL
jun	NULL
B	NULL
F.	NULL
Mollinedo	NULL
,	NULL
M.	NULL
J.	NULL
Vaquerizo	NULL
and	NULL
J.	NULL
R.	NULL
Naranjo	NULL
and	NULL
jun	NULL
D	NULL
transcripts	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
.	NULL

Densitometric	NULL
analysis	NULL
revealed	NULL
a	NULL
3-4-fold	NULL
increase	NULL
in	NULL
the	NULL
mRNA	NULL
levels	NULL
of	NULL
the	NULL
three	NULL
jun	NULL
family	NULL
members	NULL
upon	NULL
cell	NULL
treatment	NULL
with	NULL
20	NULL
ng	NULL
of	NULL
PMA/ml	NULL
for	NULL
60	NULL
min	NULL
.	NULL

The	NULL
size	NULL
of	NULL
the	NULL
c-jur	NULL
mRNA	NULL
was	NULL
about	NULL
2.7	NULL
kb	NULL
,	NULL
as	NULL
already	NULL
reported	NULL
[	NULL
1,2	NULL
]	NULL
.	NULL

A	NULL
minor	NULL
band	NULL
of	NULL
about	NULL
3.4	NULL
kb	NULL
,	NULL
suggested	NULL
to	NULL
be	NULL
a	NULL
precursor	NULL
molecule	NULL
[	NULL
1,2	NULL
]	NULL
,	NULL
was	NULL
also	NULL
evident	NULL
,	NULL
but	NULL
only	NULL
after	NULL
overexposure	NULL
of	NULL
the	NULL
autoradiogram	NULL
.	NULL

The	NULL
sizes	NULL
of	NULL
jun	NULL
B	NULL
and	NULL
jun	NULL
D	NULL
transcripts	NULL
were	NULL
about	NULL
2.1	NULL
and	NULL
2.0	NULL
kb	NULL
respectively	NULL
,	NULL
as	NULL
already	NULL
reported	NULL
[	NULL
10,21	NULL
]	NULL
.	NULL

The	NULL
level	NULL
of	NULL
expression	NULL
found	NULL
for	NULL
c-jun	NULL
mRNA	NULL
was	NULL
comparable	NULL
with	NULL
that	NULL
found	NULL
for	NULL
the	NULL
2.2	NULL
kb	NULL
c-fos	NULL
mRNA	NULL
(	NULL
[	NULL
9	NULL
]	NULL
;	NULL
F.	NULL
Mollinedo	NULL
&	NULL
J.	NULL
R.	NULL
Naranjo	NULL
,	NULL
unpublished	NULL
work	NULL
)	NULL
.	NULL

Under	NULL
the	NULL
experimental	NULL
conditions	NULL
used	NULL
in	NULL
the	NULL
Northern-blot	NULL
analysis	NULL
there	NULL
was	NULL
no	NULL
cross-hybridization	NULL
between	NULL
the	NULL
three	NULL
jun	NULL
probes	NULL
.	NULL

This	NULL
lack	NULL
of	NULL
cross-hybridization	NULL
was	NULL
evidenced	NULL
by	NULL
:	NULL
(	NULL
a	NULL
)	NULL
differences	NULL
in	NULL
the	NULL
sizes	NULL
of	NULL
the	NULL
respective	NULL
mRNAs	NULL
for	NULL
c-jun	NULL
(	NULL
~	NULL
2.7	NULL
kb	NULL
)	NULL
,	NULL
jun	NULL
B	NULL
(	NULL
~	NULL
2.1	NULL
kb	NULL
)	NULL
and	NULL
jun	NULL
D	NULL
(	NULL
~	NULL
2.0	NULL
kb	NULL
)	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
;	NULL
(	NULL
b	NULL
)	NULL
a	NULL
different	NULL
basal	NULL
and	NULL
induced	NULL
expression	NULL
of	NULL
the	NULL
three	NULL
c-jun	NULL
,	NULL
jun	NULL
B	NULL
and	NULL
jun	NULL
D	NULL
transcripts	NULL
in	NULL
granulocytes	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
;	NULL
(	NULL
c	NULL
)	NULL
a	NULL
distinct	NULL
regulation	NULL
in	NULL
the	NULL
expression	NULL
of	NULL
the	NULL
three	NULL
c-jun	NULL
,	NULL
jun	NULL
B	NULL
and	NULL
jun	NULL
D	NULL
transcripts	NULL
during	NULL
macrophage-cell	NULL
differentiation	NULL
of	NULL
U937	NULL
and	NULL
HL60	NULL
cells	NULL
induced	NULL
by	NULL
PMA	NULL
,	NULL
reaching	NULL
maximal	NULL
levels	NULL
of	NULL
jun	NULL
B	NULL
,	NULL
jun	NULL
D	NULL
and	NULL
c-jun	NULL
transcripts	NULL
after	NULL
30	NULL
min	NULL
,	NULL
6	NULL
h	NULL
and	NULL
24	NULL
h	NULL
of	NULL
induction	NULL
respectively	NULL
(	NULL
F.	NULL
Mollinedo	NULL
&	NULL
J.	NULL
R.	NULL
Naranjo	NULL
,	NULL
unpublished	NULL
work	NULL
)	NULL
.	NULL

Time-course	NULL
experiments	NULL
showed	NULL
,	NULL
by	NULL
dot-blot	NULL
analysis	NULL
,	NULL
that	NULL
jun	NULL
B	NULL
,	NULL
jun	NULL
D	NULL
and	NULL
c-jun	NULL
mRNA	NULL
levels	NULL
were	NULL
augmented	NULL
as	NULL
early	NULL
as	NULL
15-30	NULL
min	NULL
after	NULL
the	NULL
addition	NULL
of	NULL
PMA	NULL
,	NULL
reaching	NULL
their	NULL
maximal	NULL
levels	NULL
(	NULL
3-4-fold	NULL
increase	NULL
)	NULL
at	NULL
60	NULL
min	NULL
.	NULL

Thereafter	NULL
,	NULL
jun	NULL
B	NULL
,	NULL
jun	NULL
D	NULL
and	NULL
c-jun	NULL
mRNA	NULL
levels	NULL
decreased	NULL
to	NULL
values	NULL
close	NULL
to	NULL
the	NULL
preinduction	NULL
levels	NULL
within	NULL
2	NULL
h	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

The	NULL
results	NULL
herein	NULL
reported	NULL
demonstrate	NULL
for	NULL
the	NULL
first	NULL
time	NULL
that	NULL
c-jun	NULL
,	NULL
jun	NULL
B	NULL
and	NULL
jun	NULL
D	NULL
proto-oncogenes	NULL
are	NULL
expressed	NULL
constitutively	NULL
in	NULL
freshly	NULL
isolated	NULL
human	NULL
peripheral-blood	NULL
granulocytes	NULL
and	NULL
that	NULL
the	NULL
basal	NULL
levels	NULL
of	NULL
the	NULL
three	NULL
c-jun	NULL
,	NULL
jun	NULL
B	NULL
and	NULL
jun	NULL
D	NULL
mRNAs	NULL
are	NULL
increased	NULL
by	NULL
functional	NULL
granulocyte	NULL
activation	NULL
with	NULL
PMA	NULL
.	NULL

Furthermore	NULL
,	NULL
as	NULL
mature	NULL
granulocytes	NULL
do	NULL
not	NULL
proliferate	NULL
and	NULL
are	NULL
unable	NULL
to	NULL
undergo	NULL
further	NULL
differentiation	NULL
,	NULL
these	NULL
results	NULL
also	NULL
demonstrate	NULL
that	NULL
the	NULL
three	NULL
c-jun	NULL
,	NULL
jun	NULL
B	NULL
and	NULL
jun	NULL
D	NULL
genes	NULL
are	NULL
expressed	NULL
in	NULL
a	NULL
terminally	NULL
differentiated	NULL
non-proliferating	NULL
cell	NULL
type	NULL
.	NULL

The	NULL
three	NULL
jun	NULL
proto-oncogenes	NULL
studied	NULL
have	NULL
been	NULL
shown	NULL
to	NULL
be	NULL
associated	NULL
with	NULL
c-Fos	NULL
or	NULL
Fos-related	NULL
proteins	NULL
to	NULL
form	NULL
transcriptional	NULL
regulators	NULL
[	NULL
3-8	NULL
]	NULL
.	NULL

Thus	NULL
the	NULL
data	NULL
reported	NULL
here	NULL
suggest	NULL
that	NULL
expression	NULL
of	NULL
jun	NULL
and	NULL
fos	NULL
proto-oncogenes	NULL
might	NULL
be	NULL
involved	NULL
in	NULL
regulating	NULL
gene	NULL
expression	NULL
related	NULL
to	NULL
granulocyte	NULL
functionality	NULL
or	NULL
terminal	NULL
cell	NULL
differentiation	NULL
.	NULL

We	NULL
thank	NULL
the	NULL
Hospital	NULL
Santiago	NULL
Ramon	NULL
y	NULL
Cajal	NULL
Blood	NULL
Bank	NULL
for	NULL
providing	NULL
us	NULL
with	NULL
fresh	NULL
human	NULL
peripheral	NULL
blood	NULL
.	NULL

This	NULL
work	NULL
was	NULL
supported	NULL
by	NULL
Grant	NULL
PM	NULL
89-0003	NULL
from	NULL
the	NULL
Direccion	NULL
General	NULL
de	NULL
Investigacion	NULL
Cientifica	NULL
y	NULL
Técnica	NULL
(	NULL
to	NULL
F.	NULL
M.	NULL
)	NULL
and	NULL
by	NULL
a	NULL
Grant	NULL
from	NULL
the	NULL
Fundacion	NULL
Ramon	NULL
Areces	NULL
(	NULL
to	NULL
J.	NULL
R.	NULL
N.	NULL
)	NULL
.	NULL

REFERENCES	NULL
1	NULL
.	NULL

Bohman	NULL
,	NULL
D.	NULL
,	NULL
Bos	NULL
,	NULL
T.	NULL
J.	NULL
,	NULL
Admon	NULL
,	NULL
A.	NULL
,	NULL
Nishimura	NULL
,	NULL
T.	NULL
,	NULL
Vogt	NULL
,	NULL
P.	NULL
K.	NULL
&	NULL
Tjian	NULL
,	NULL
R.	NULL
(	NULL
1987	NULL
)	NULL
Science	NULL
238	NULL
,	NULL
1386-1392	NULL
2	NULL
.	NULL

Angel	NULL
,	NULL
P.	NULL
,	NULL
Allegretto	NULL
,	NULL
E.	NULL
A.	NULL
,	NULL
Okino	NULL
,	NULL
S.	NULL
T.	NULL
,	NULL
Hattari	NULL
,	NULL
K.	NULL
,	NULL
Boyle	NULL
,	NULL
W.	NULL
J.	NULL
,	NULL
Hunter	NULL
,	NULL
T.	NULL
&	NULL
Karin	NULL
,	NULL
M.	NULL
(	NULL
1988	NULL
)	NULL
Nature	NULL
(	NULL
London	NULL
)	NULL
332	NULL
,	NULL
166-171	NULL
3	NULL
.	NULL

Sassone-Corsi	NULL
,	NULL
P.	NULL
,	NULL
Ransome	NULL
,	NULL
L.	NULL
J.	NULL
,	NULL
Lamph	NULL
,	NULL
W.	NULL
W.	NULL
&	NULL
Verma	NULL
,	NULL
I.	NULL
M.	NULL
(	NULL
1988	NULL
)	NULL
Nature	NULL
(	NULL
London	NULL
)	NULL
336	NULL
,	NULL
692-695	NULL
4	NULL
.	NULL

Rauscher	NULL
,	NULL
F.	NULL
J.	NULL
,	NULL
III	NULL
,	NULL
Sambucetti	NULL
,	NULL
L.	NULL
C.	NULL
,	NULL
Curran	NULL
,	NULL
T.	NULL
,	NULL
Distel	NULL
,	NULL
R.J.	NULL
&	NULL
Spiegelman	NULL
,	NULL
B.	NULL
M.	NULL
(	NULL
1988	NULL
)	NULL
Cell	NULL
(	NULL
Cambridge	NULL
,	NULL
Mass	NULL
.	NULL
)	NULL

52	NULL
,	NULL
471-480	NULL
5	NULL
.	NULL

Franza	NULL
,	NULL
B.	NULL
R.	NULL
,	NULL
Jr.	NULL
,	NULL
Rauscher	NULL
,	NULL
F.	NULL
J.	NULL
,	NULL
IH	NULL
,	NULL
Josephs	NULL
S.	NULL
F	NULL
&	NULL
Curran	NULL
T.	NULL
(	NULL
1988	NULL
)	NULL
Science	NULL
239	NULL
1150-1153	NULL
'	NULL
6	NULL
.	NULL

Halazonetis	NULL
,	NULL
T.	NULL
D.	NULL
,	NULL
Georgopoulos	NULL
,	NULL
K.	NULL
,	NULL
Greenberg	NULL
,	NULL
M	NULL
E	NULL
&	NULL
Leder	NULL
P.	NULL
(	NULL
1988	NULL
)	NULL
Cell	NULL
(	NULL
Cambridge	NULL
,	NULL
Mass	NULL
.	NULL
)	NULL

55	NULL
,	NULL
917	NULL
924	NULL
7	NULL
.	NULL

Ryder	NULL
,	NULL
K.	NULL
,	NULL
Lau	NULL
,	NULL
.	NULL

L.-F.	NULL
&	NULL
Nathans	NULL
,	NULL
.	NULL

D.	NULL
(	NULL
1988	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.S.A.	NULL
85	NULL
,	NULL
8464-8467	NULL
1991	NULL
Expression	NULL
of	NULL
jun	NULL
proto-oncogenes	NULL
in	NULL
human	NULL
blood	NULL
granulocytes	NULL
479	NULL
Time	NULL
(	NULL
min	NULL
)	NULL
...	NULL
0	NULL
__	NULL
15	NULL
60	NULL
120	NULL
0	NULL
-	NULL
15	NULL
60	NULL
_	NULL
120	NULL
0	NULL
_	NULL
15	NULL
60	NULL
120	NULL
RNA	NULL
RNA	NULL
RNA	NULL
(	NULL
ug	NULL
)	NULL
(	NULL
ug	NULL
)	NULL
(	NULL
ug	NULL
)	NULL
10	NULL
.	NULL

.	NULL

‘	NULL
10	NULL
3	NULL
®	NULL
.	NULL

@	NULL
10	NULL
_	NULL
®	NULL
%	NULL
.	NULL

#	NULL
>	NULL
%	NULL
0	NULL
@	NULL
5	NULL
°	NULL
>	NULL
*	NULL
&	NULL
®	NULL
5	NULL
©	NULL
¢	NULL
e	NULL
-	NULL
e	NULL
0	NULL
e	NULL
®	NULL
|	NULL
0.5	NULL
a	NULL
e	NULL
0.5	NULL
0.5	NULL
[	NULL
T	NULL
I	NULL
|	NULL
pa	NULL
un	NULL
B	NULL
|	NULL
jun	NULL
D	NULL
|	NULL
c-jun	NULL
|	NULL
©	NULL
|	NULL
|	NULL
‘	NULL
i	NULL
|	NULL
o\	NULL
|	NULL
|	NULL
|	NULL
<	NULL
4	NULL
}	NULL
/	NULL
|	NULL
|	NULL
|	NULL
z	NULL
.	NULL

|	NULL
|	NULL
«	NULL
i	NULL
/	NULL
\	NULL
|	NULL
/\	NULL
|	NULL
T	NULL
&	NULL
]	NULL
/	NULL
|	NULL
J	NULL
%	NULL
|	NULL
a	NULL
3	NULL
#	NULL
\	NULL
1/\	NULL
|	NULL
/	NULL
\	NULL
ﬁ	NULL
9	NULL
\	NULL
/	NULL
\	NULL
|	NULL
P4	NULL
\	NULL
|	NULL
9	NULL
X	NULL
|	NULL
/	NULL
\	NULL
l	NULL
[	NULL
\	NULL
|	NULL
gel	NULL
,	NULL
o	NULL
|	NULL
v	NULL
=	NULL
1	NULL
f	NULL
\	NULL
|	NULL
/	NULL
\	NULL
|	NULL
l	NULL
\	NULL
.	NULL

|	NULL
e	NULL
»	NULL
es	NULL
|	NULL
/	NULL
|	NULL
2	NULL
}	NULL
3	NULL
l	NULL
&	NULL
~	NULL
|	NULL
e	NULL
|	NULL
.	NULL

4	NULL
1	NULL
[	NULL
og	NULL
i_	NULL
o	NULL
I	NULL
0	NULL
30	NULL
60	NULL
90	NULL
120	NULL
0	NULL
30	NULL
60	NULL
90	NULL
120	NULL
o	NULL
30	NULL
60	NULL
90	NULL
120	NULL
Time	NULL
after	NULL
PMA	NULL
addition	NULL
(	NULL
min	NULL
)	NULL
Fig	NULL
.	NULL

2	NULL
.	NULL

Time	NULL
course	NULL
of	NULL
jun	NULL
B	NULL
,	NULL
jun	NULL
D	NULL
and	NULL
c-jun	NULL
mRNA	NULL
induction	NULL
by	NULL
PMA	NULL
in	NULL
human	NULL
peripheral-blood	NULL
granulocytes	NULL
Cells	NULL
were	NULL
exposed	NULL
for	NULL
the	NULL
indicated	NULL
times	NULL
to	NULL
PMA	NULL
(	NULL
20	NULL
ng/m	NULL
!	NULL
)	NULL

at	NULL
37	NULL
°C	NULL
.	NULL

Total	NULL
RNA	NULL
was	NULL
isolated	NULL
and	NULL
dot-blot	NULL
analysis	NULL
was	NULL
carried	NULL
out	NULL
as	NULL
described	NULL
in	NULL
the	NULL
Materials	NULL
and	NULL
methods	NULL
section	NULL
.	NULL

Specific	NULL
mRNA	NULL
contents	NULL
were	NULL
.	NULL

quantified	NULL
by	NULL
densitometric	NULL
scanning	NULL
of	NULL
the	NULL
autoradiograms	NULL
.	NULL

Values	NULL
were	NULL
corrected	NULL
for	NULL
variations	NULL
in	NULL
$	NULL
-actin	NULL
mRNA	NULL
content	NULL
.	NULL

Data	NULL
are	NULL
means	NULL
for	NULL
densitometric	NULL
scans	NULL
from	NULL
three	NULL
independent	NULL
dot-blots	NULL
.	NULL

Standard	NULL
errors	NULL
were	NULL
between	NULL
5	NULL
and	NULL
7	NULL
%	NULL
.	NULL

Autoradiograms	NULL
were	NULL
developed	NULL
after	NULL
24	NULL
h	NULL
of	NULL
exposure	NULL
.	NULL

The-	NULL
upper	NULL
part	NULL
of	NULL
the	NULL
Figure	NULL
shows	NULL
a	NULL
representative	NULL
dot-blot	NULL
of	NULL
cells	NULL
treated	NULL
with	NULL
PMA	NULL
(	NULL
20	NULL
ng/ml	NULL
)	NULL
.	NULL

.	NULL

Nakabeppu	NULL
,	NULL
Y.	NULL
,	NULL
Ryder	NULL
,	NULL
K.	NULL
&	NULL
Nathans	NULL
,	NULL
D.	NULL
(	NULL
1988	NULL
)	NULL
Cell	NULL
(	NULL
Cambridge	NULL
,	NULL
Mass	NULL
.	NULL
)	NULL

55	NULL
,	NULL
907-915	NULL
.	NULL

Colotta	NULL
,	NULL
F.	NULL
,	NULL
Wang	NULL
,	NULL
J.	NULL
M.	NULL
,	NULL
Polentarutti	NULL
,	NULL
N.	NULL
&	NULL
Mantovani	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1987	NULL
)	NULL
J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

165	NULL
,	NULL
1224-1229	NULL
.	NULL

Heidorn	NULL
,	NULL
K.	NULL
,	NULL
Kreipe	NULL
,	NULL
H.	NULL
,	NULL
Radzun	NULL
,	NULL
H.	NULL
J.	NULL
,	NULL
Miiller	NULL
,	NULL
R.	NULL
&	NULL
Parwaresch	NULL
,	NULL
M.	NULL
R.	NULL
(	NULL
1987	NULL
)	NULL
Blood	NULL
70	NULL
,	NULL
456-459	NULL
.	NULL

Kreipe	NULL
,	NULL
H.	NULL
,	NULL
Radzun	NULL
,	NULL
H.	NULL
J.	NULL
,	NULL
Heidorn	NULL
,	NULL
K.	NULL
,	NULL
Mider	NULL
,	NULL
C.	NULL
&	NULL
Parwaresch	NULL
,	NULL
M.	NULL
R.	NULL
(	NULL
1987	NULL
)	NULL
J.	NULL
Histochem	NULL
.	NULL

Cytochem	NULL
.	NULL

35	NULL
,	NULL
837-842	NULL
.	NULL

Sariban	NULL
,	NULL
E.	NULL
,	NULL
Mitchell	NULL
,	NULL
T.	NULL
,	NULL
Rambaidi	NULL
,	NULL
A	NULL
.	NULL

&	NULL
Kufe	NULL
,	NULL
D.	NULL
W.	NULL
(	NULL
1988	NULL
)	NULL
Blood	NULL
71	NULL
,	NULL
488-493	NULL
.	NULL

Itami	NULL
,	NULL
M.	NULL
,	NULL
Kuroki	NULL
,	NULL
T.	NULL
&	NULL
Nose	NULL
,	NULL
K.	NULL
(	NULL
1987	NULL
)	NULL
FEBS	NULL
Lett	NULL
.	NULL

222	NULL
,	NULL
289-292	NULL
.	NULL

Bertani	NULL
,	NULL
A.	NULL
,	NULL
Bolentarutti	NULL
,	NULL
N.	NULL
,	NULL
Sica	NULL
,	NULL
A.	NULL
,	NULL
Rambaldi	NULL
,	NULL
A.	NULL
,	NULL
Mantovani	NULL
,	NULL
A	NULL
.	NULL

&	NULL
Colotta	NULL
,	NULL
F.	NULL
(	NULL
1989	NULL
)	NULL
Blood	NULL
74	NULL
,	NULL
1811-1816	NULL
.	NULL

Mollinedo	NULL
,	NULL
F.	NULL
,	NULL
Nieto	NULL
,	NULL
J.	NULL
M.	NULL
&	NULL
Andreu	NULL
,	NULL
J.	NULL
M.	NULL
(	NULL
1989	NULL
)	NULL
Mol	NULL
.	NULL

Pharmacol	NULL
.	NULL

36	NULL
,	NULL
547-555	NULL
Received	NULL
24	NULL
July	NULL
1990/31	NULL
October	NULL
1990	NULL
;	NULL
accepted	NULL
12	NULL
November	NULL
1990	NULL
Vol	NULL
.	NULL

273	NULL
16	NULL
.	NULL

17	NULL
.	NULL

18	NULL
.	NULL

19	NULL
.	NULL

20	NULL
.	NULL

21	NULL
.	NULL

22	NULL
.	NULL

Collins	NULL
,	NULL
S.J	NULL
.	NULL

,	NULL
Gallo	NULL
,	NULL
R.C	NULL
.	NULL

&	NULL
Gallagher	NULL
,	NULL
(	NULL
London	NULL
)	NULL
270	NULL
,	NULL
347-349	NULL
Chirgwin	NULL
,	NULL
J.	NULL
M.	NULL
,	NULL
Przybyla	NULL
,	NULL
A.	NULL
E.	NULL
,	NULL
MacDonald	NULL
,	NULL
R.	NULL
J	NULL
.	NULL

&	NULL
Rutter	NULL
,	NULL
W.	NULL
J	NULL
.	NULL

(	NULL
1979	NULL
)	NULL
Biochemistry	NULL
18	NULL
,	NULL
5294-5299	NULL
Maniatis	NULL
,	NULL
T.	NULL
,	NULL
Fritch	NULL
,	NULL
E.	NULL
F.	NULL
&	NULL
Sambrook	NULL
,	NULL
J	NULL
.	NULL

(	NULL
1982	NULL
)	NULL
Molecular	NULL
Cloning	NULL
,	NULL
A	NULL
Laboratory	NULL
Manual	NULL
,	NULL
Cold	NULL
Spring	NULL
Harbor	NULL
Laboratory	NULL
,	NULL
Cold	NULL
Spring	NULL
Harbor	NULL
,	NULL
NY	NULL
Ryseck	NULL
,	NULL
R.-P.	NULL
,	NULL
Hirai	NULL
,	NULL
S.	NULL
I.	NULL
,	NULL
Yaniv	NULL
,	NULL
M.	NULL
&	NULL
Bravo	NULL
,	NULL
R.	NULL
(	NULL
1988	NULL
)	NULL
Nature	NULL
(	NULL
London	NULL
)	NULL
334	NULL
,	NULL
535-537	NULL
Ryder	NULL
,	NULL
K.	NULL
,	NULL
Lau	NULL
,	NULL
L.	NULL
F.	NULL
&	NULL
Nathans	NULL
,	NULL
D.	NULL
(	NULL
1988	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.S.A.	NULL
85	NULL
,	NULL
1487-1491	NULL
Hirai	NULL
,	NULL
S.-I	NULL
.	NULL

,	NULL
Ryseck	NULL
,	NULL
R.-P.	NULL
,	NULL
Mechta	NULL
,	NULL
F.	NULL
,	NULL
Bravo	NULL
,	NULL
R.	NULL
&	NULL
Yaniv	NULL
,	NULL
M.	NULL
(	NULL
1989	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

8	NULL
,	NULL
1433-1439	NULL
Nudel	NULL
,	NULL
U.	NULL
,	NULL
Zakut	NULL
,	NULL
R.	NULL
,	NULL
Shani	NULL
,	NULL
M.	NULL
,	NULL
Neuman	NULL
,	NULL
S.	NULL
,	NULL
Levy	NULL
,	NULL
Z	NULL
.	NULL

&	NULL
Yaffe	NULL
,	NULL
D	NULL
(	NULL
1983	NULL
)	NULL
Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

11	NULL
,	NULL
1759-1771	NULL
R.	NULL
E.	NULL
(	NULL
1977	NULL
)	NULL
Nature	NULL

